Drug Profile
Pseudomonas vaccine - CJ Corporation
Alternative Names: CFC-101Latest Information Update: 07 Dec 2006
Price :
$50
*
At a glance
- Originator CJ Corporation
- Class Bacterial vaccines; Pseudomonas vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pseudomonal infections
Most Recent Events
- 19 Aug 2003 Phase-III clinical trials in Pseudomonal infections in South Korea (IM)
- 23 Dec 2002 Cheil Jedang is now called CJ Corporation
- 14 Jun 2000 Phase-II clinical trials for Pseudomonal infections in South Korea (IM)